London, Nov 16 : Research on cancer drug is entering a whole new era, which will lead to more successful drugs for patients, according to a charity.
Experts at Cancer Research UK have said that improved knowledge of cancer''s biology means 18 percent of new drugs, compared to 5 percent previously - will become standard treatments.
The hunt for cancer drugs is conducted on a large scale, but there is also a massive failure rate, as promising candidates fall by the wayside in clinical trials.
Although scientists can learn lessons even from expensive failures, this costs drug firms and charities such as Cancer Research UK many millions.